Oxyora (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxyora, is an opioid analgesic presented as a strength/form for oral use. It is prescribed for managing moderate to severe pain in adult patients when other treatments are insufficient.

GNH USA supplies Oxyora as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxycodone Hydrochloride is used in the management of pain through its action on the central nervous system. - Acute postoperative pain: Provides relief when pain is expected after surgery. - Cancer‑related pain: Helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: Used when long‑term analgesia is required and other options are inadequate.

Adverse reactions to oxycodone may vary in frequency and severity.

Common Side Effects: - Constipation: Reduced gastrointestinal motility. - Nausea: Upset stomach often accompanied by a feeling of queasiness. - Drowsiness: Increased sleepiness or sedation. - Dizziness: Light‑headed feeling, especially when standing quickly. - Dry mouth: Reduced salivation leading to a parched sensation. - Itching: Mild skin irritation or pruritus.

Serious or Rare Side Effects: - Respiratory depression: Slowed or shallow breathing that can be life‑threatening. - Severe hypotension: Markedly low blood pressure. - Seizures: Uncontrolled electrical activity in the brain. - Allergic reactions: Hives, swelling, or anaphylaxis. - Dependence and withdrawal: Physical and psychological reliance with withdrawal symptoms on cessation. - Adrenal cortisol suppression: Hormonal imbalance affecting stress response.

When prescribing oxycodone, clinicians should evaluate patient history and monitor for adverse outcomes. - Assess pain severity: Confirm that opioid therapy is appropriate for the level of pain. - Review medical history: Identify respiratory disorders, head injury, or substance‑use disorder. - Monitor for sedation: Observe for excessive drowsiness or impaired cognition. - Avoid concurrent CNS depressants: Limit use of alcohol, benzodiazepines, or other sedatives. - Educate on dependence risk: Inform patients about the potential for tolerance and addiction. - Store below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Oxycodone may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: Combined use can cause profound respiratory depression. - Central nervous system depressants: Concurrent alcohol or barbiturates heightens sedation and respiratory risk. - MAO‑Inhibitors: May precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors: Drugs such as ketoconazole increase oxy‑cysteine ?? - CYP3A4 inducers:  -  -